Marketing-Börse PLUS - Fachbeiträge zu Marketing und Digitalisierung
print logo

Dementia Associated With Alzheimer's Disease Therapeutics Drugs and Companies PipelineReview H1 2015

ResearchMoz added Latest Research Report titled " Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2015 - Markets and Research "
Sagar Jagtap | 10.06.2016

Global Markets Directs, Dementia Associated With Alzheimer's Disease Pipeline Review, H1 2015, provides an overview of the Dementia Associated With Alzheimer's Diseases therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Dementia Associated With Alzheimer's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dementia Associated With Alzheimer's Disease and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.

Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=286067

Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

The report provides a snapshot of the global therapeutic landscape of Dementia Associated With Alzheimer's Disease
The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in the therapeutics development for Dementia Associated With Alzheimer's Disease and enlists all their major and minor projects
The report summarizes all the dormant and discontinued pipeline projects
A review of the Dementia Associated With Alzheimer's Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Dementia Associated with Alzheimer's disease Overview 6
Therapeutics Development 7
Pipeline Products for Dementia Associated With Alzheimer's Disease - Overview 7
Pipeline Products for Dementia Associated With Alzheimer's Disease - Comparative Analysis 8
Dementia Associated With Alzheimer's Disease - Therapeutics under Development by Companies 9
Dementia Associated With Alzheimer's Disease - Therapeutics under Investigation by Universities/Institutes 10
Dementia Associated With Alzheimer's Disease - Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Early Stage Products 13
Dementia Associated With Alzheimer's Disease - Products under Development by Companies 14
Dementia Associated With Alzheimer's Disease - Products under Investigation by Universities/Institutes 15
Dementia Associated With Alzheimer's Disease - Companies Involved in Therapeutics Development 16
Actinogen Limited 16
Chase Pharmaceuticals Corporation 17
Eisai Co., Ltd. 18
FORUM Pharmaceuticals Inc. 19
MediPost Co., Ltd. 20

Related Report

Global Alzheimer's Disease Drug Industry 2016
Read Full Report @ http://www.researchmoz.us/global-alzheimers-disease-drug-industry-2016-market-research-report-report.html

The Global Alzheimer's Disease Drug Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Alzheimer's Disease Drug industry.Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Alzheimer's Disease Drug market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

About the tenderer: Sagar Jagtap